Page last updated: 2024-08-16

linsidomine and 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate

linsidomine has been researched along with 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bucher, B; Butt, E; Genieser, HG; Huggins, JP; Pöhler, D1

Other Studies

1 other study(ies) available for linsidomine and 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate

ArticleYear
Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
    British journal of pharmacology, 1995, Volume: 116, Issue:8

    Topics: Animals; Base Sequence; Blood Platelets; Cattle; Cell Adhesion Molecules; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Humans; In Vitro Techniques; Microfilament Proteins; Molecular Sequence Data; Molsidomine; Muscle, Smooth, Vascular; Norepinephrine; Phosphoproteins; Phosphorylation; Rats; Stereoisomerism; Thionucleotides; Vasoconstriction; Vasodilator Agents

1995